Saudi's Avalon Pharma Posts Qtrly Profit
MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY 44016:
QTRLY NET PROFIT 9.37 MILLION RIYALS VERSUS LOSS 0.5 MILLION RIYALS YEAR AGO
QTRLY SALES 75.82 MILLION RIYALS VERSUS 55.23 MILLION RIYALS YEAR AGO
QUARTER SAW STRONG SALES PERFORMANCE IN ALL DISTRIBUTION CHANNELS